Gregory P Adams

基本信息

Career Trajectory

Bio

I serve on the Editorial Boards of Cancer Immunology Research, MAbs and Cancer Biotherapy & Radiopharmaceuticals and rotated off the editorial board of Cancer Research. I was a member of the Integration Panel of the Department of Defense's Breast Cancer Research Program and served as a reviewer for other panels including the NCI and the ACS and am a member of the Antibody Society's Board of Directors. Prior to joining Viventia Bio I was an adviser to biotech companies such as Endo Pharmaceuticals, Mersana, Symphogen, Avipep, AvidBiologics. I was as an expert witness for Centocor/J&J in a patent infringement lawsuit against Abbott (Remicade vs. Humira).

Research Interests

Papers共 222 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Organization of Microtubule Plus-End Dynamics by Phase Separation in Mitosis

Fengrui Yang,Mingrui Ding,Xiaoyu Song,Fang Chen,Tongtong Yang,Chunyue Wang, Chengcheng Hu, Qing Hu,Yihan Yao,Shihao Du,Phil Y. Yao,Peng Xia,Gregory Adams Jr,Chuanhai Fu,Shengqi Xiang,Dan Liu,Zhikai Wang,Kai Yuan,Xing Liu

JOURNAL OF MOLECULAR CELL BIOLOGYno. 2 (2024)

Cited0Views0WOSBibtex

Phase 1 Trial of a Novel C’Dot Drug Conjugate (CDC), ELU001, in Patients with Solid Tumors Known to Overexpress Folate Receptor Alpha (Frα)

Wen Wee Ma,Anthony W. Tolcher,Cesar Augusto Perez,Douglas Orr,Erika P. Hamilton,Yujie Zhao,Yonina R. Murciano-Goroff,Carey K. Anders,Gregory Paul Adams, Catherine W. Reddick,Eliel Bayever

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

Cited0Views0Bibtex

Supplementary Figure S2 from Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer

Andrea M. Patterson,Saghar Kaabinejadian,Curtis McMurtrey,Wilfried Bardet,Ken W. Jackson,Rosemary E. Zuna,Sanam Husain,Gregory P. Adams, Glen M. MacDonald,Rachelle L. Dillon,Harold Ames,Rico Buchli,Oriana E. Hawkins,Jon A. Weidanz,William H. Hildebrand

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 1 from Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors

Stephen I. Rudnick,Jianlong Lou,Calvin C. Shaller, Yong Tang,Andres J.P. Klein-Szanto,Louis M. Weiner,James D. Marks,Gregory P. Adams

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure 4 from Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity

Yu Cao,James D. Marks, Qian Huang,Stephen I. Rudnick,Chiyi Xiong,Walter N. Hittelman,Xiaoxia Wen,John W. Marks,Lawrence H. Cheung,Kim Boland,Chun Li,Gregory P. Adams,Michael G. Rosenblum

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure Legends 1-10, Table 2 from Targeting C4-Demethylating Genes in the Cholesterol Pathway Sensitizes Cancer Cells to EGF Receptor Inhibitors Via Increased EGF Receptor Degradation

Anna Sukhanova,Andrey Gorin, Ilya G. Serebriiskii,Linara Gabitova,Hui Zheng,Diana Restifo,Brian L. Egleston,David Cunningham, Tetyana Bagnyukova,Hanqing Liu,Anna S. Nikonova,Gregory P. Adams,Yan Zhou, Di Yang,Ranee Mehra,Barbara Burtness,Kathy Q. Cai,Andres J. Klein‐Szanto,Lisa E. Kratz,Richard I. Kelley,Louis M. Weiner,Gail E. Herman, Erica A. Golemis,Igor Astsaturov

openalex

Cited0Views0Bibtex

Abstract CT255: ELU-FRα-1: a Study to Evaluate ELU001 in Patients with Solid Tumors That Overexpress Folate Receptor Alpha (Frα)

Wen Wee,Anthony W. Tolcher,Cesar A. Perez, Douglass Orr,Erika Hamilton,Yujie Zhao,Yonina R. Murciano‐Goroff,Carey K. Anders,Gregory P. Adams, Catherine W. Reddick,Eliel Bayever

Cancer Researchno. 8_Supplement (2023): CT255-CT255

Cited1Views0Bibtex

Preclinical Development of ELU001: A Folate Receptor Alpha (Frα)-Targeted C'Dot Drug Conjugate (CDC) for the Treatment of Brain Metastases

Gregory P. Adams,Tin Khor,Feng Chen,Kai Ma,Marion Scocca,Aranapakam Venkatesan,Cathy Reddick,Mary Hilgart,Thomas Gardinier, Fei Wu,Melik Turker,Peiming Chen,Vaibhav Patel,Eliel Bayever

CANCER RESEARCHno. 7 (2023)

Cited0Views0Bibtex

Supplementary Figure Legends from Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer

openalex（2023）

Cited0Views0Bibtex

Abstract 837: Preclinical Development of ELU001: A Folate Receptor Alpha (Frα)-Targeted C’Dot Drug Conjugate (CDC) for the Treatment of Brain Metastases

Gregory P. Adams,Tin Khor,Feng Chen,Kai Ma,Marion Scocca,Aranapakam Venkatesan,Cathy Reddick,Mary Hilgart,Thomas Gardinier,Fei Wu,Melik Turker,Peiming Chen,Vaibhav Patel,Eliel Bayever

Cancer Researchno. 7_Supplement (2023): 837-837

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Chief Scientific Officer

Papers共 222 篇Author StatisticsCo-AuthorSimilar Experts